These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21387676)

  • 21. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions.
    Geisler T; Zürn C; Simonenko R; Rapin M; Kraibooj H; Kilias A; Bigalke B; Stellos K; Schwab M; May AE; Herdeg C; Gawaz M
    Eur Heart J; 2010 Jan; 31(1):59-66. PubMed ID: 19812059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late stent thrombosis in brachytherapy: the role of long-term antiplatelet therapy.
    Teirstein P; Reilly JP
    J Invasive Cardiol; 2002 Mar; 14(3):109-14. PubMed ID: 11870263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
    Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.
    Eshtehardi P; Windecker S; Cook S; Billinger M; Togni M; Garachemani A; Meier B; Hess OM; Wenaweser P
    Am Heart J; 2010 May; 159(5):891-898.e1. PubMed ID: 20435201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stents and antiplatelet therapy.
    Fassa AA; Urban P
    Adv Cardiol; 2012; 47():114-24. PubMed ID: 22906907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation.
    Ferreira-González I; Marsal JR; Ribera A; Permanyer-Miralda G; García-Del Blanco B; Martí G; Cascant P; Martín-Yuste V; Brugaletta S; Sabaté M; Alfonso F; Capote ML; De La Torre JM; Ruíz-Lera M; Sanmiguel D; Cárdenas M; Pujol B; Baz JA; Iñiguez A; Trillo R; González-Béjar O; Casanova J; Sánchez-Gila J; García-Dorado D
    Circulation; 2010 Sep; 122(10):1017-25. PubMed ID: 20733100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.
    Jensen LO; Tilsted HH; Thayssen P; Kaltoft A; Maeng M; Lassen JF; Hansen KN; Madsen M; Ravkilde J; Johnsen SP; Sørensen HT; Thuesen L
    EuroIntervention; 2010 Apr; 5(8):898-905. PubMed ID: 20542774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
    Dai X; Makaryus AN; Makaryus JN; Jauhar R
    Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late coronary thrombosis in paclitaxel-eluting stents. Case reports.
    Cassin M; De Biasio M; Macor F; Burelli C; Vendrametto F; Driussi M; Nicolosi GL
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):284-8. PubMed ID: 17413307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Rossini R; Musumeci G; Aprile A; Valsecchi O
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):49-61. PubMed ID: 20121564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.
    Chen TH; Matyal R
    Semin Cardiothorac Vasc Anesth; 2010 Dec; 14(4):256-73. PubMed ID: 21059610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up on a large cohort of "full-metal jacket" percutaneous coronary intervention procedures.
    Sharp AS; Latib A; Ielasi A; Larosa C; Godino C; Saolini M; Magni V; Gerber RT; Montorfano M; Carlino M; Michev I; Chieffo A; Colombo A
    Circ Cardiovasc Interv; 2009 Oct; 2(5):416-22. PubMed ID: 20031751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug-eluting stents: HOME DES registry.
    Cervinka P; Jakabcin J; Jäger J; Veselka J; Kala P; Maly J
    Coron Artery Dis; 2007 Nov; 18(7):577-81. PubMed ID: 17925613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.